We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02888379
Brief Title: Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis (TOP2)

First Submitted : August 30, 2016
First Submitted that Met QC Criteria : August 30, 2016
First Posted : September 5, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 6, 2017
Last Update Posted : July 7, 2017